Search the Appendices of Resolution CM/Res(2018)1
2416 found
| INN | ATC Code ▲ | Country | Classification | Last update | MA Number | Registration date | Status | |
|---|---|---|---|---|---|---|---|---|
| TRASTUZUMAB DERUXTECAN | L01FD04 | IT | I | 19-10-2021 | EMEA/H/C/005124 | 18-01-2021 | VALID | |
| PANITUMUMAB | L01FE02 | IT | I | None | VALID | |||
| NECITUMUMAB | L01FE03 | IT | Not authorised | 27-01-2022 | VALID | |||
| NIVOLUMAB | L01FF01 | IT | I | 26-02-2020 | EMEA/H/C/003985 | 19-06-2015 | VALID | |
| PEMBROLIZUMAB | L01FF02 | IT | I | 27-01-2022 | EMEA/H/C/003820 | 17-07-2015 | VALID | |
| DURVALUMAB | L01FF03 | IT | I | 26-02-2020 | VALID | |||
| AVELUMAB | L01FF04 | IT | I | VALID | ||||
| ATEZOLIZUMAB | L01FF05 | IT | I | VALID | ||||
| CEMIPLIMAB | L01FF06 | IT | I | EMEA/H/C/004844 | 27-06-2019 | VALID | ||
| DOSTARLIMAB | L01FF07 | IT | I | 19-10-2021 | EMEA/H/C/005204 | 21-04-2021 | VALID | |
| TISLELIZUMAB | L01FF09 | IT | I | 14-11-2023 | EMEA/H/C/005919 | 15-09-2023 | VALID | |
| RETIFANLIMAB | L01FF10 | IT | POM | 01-08-2025 | EMEA/H/C/006194 | 19-04-2024 | VALID | |
| TORIPALIMAB | L01FF13 | IT | POM | 01-08-2025 | EMEA/H/C/006120 | 19-09-2024 | VALID | |
| RAMUCIRUMAB | L01FG02 | IT | I | VALID | ||||
| GEMTUZUMAB OZOGAMICIN | L01FX02 | IT | I | 17-12-2018 | EMEA/H/C/004204 | 21-09-2018 | VALID | |
| IPILIMUMAB | L01FX04 | IT | I | VALID | ||||
| BRENTUXIMAB VEDOTIN | L01FX05 | IT | I | VALID | ||||
| DINUTUXIMAB BETA | L01FX06 | IT | I | 27-01-2022 | VALID | |||
| BLINATUMOMAB | L01FX07 | IT | I | 19-02-2019 | EMEA/H/C/003731 | 23-11-2015 | VALID | |
| ELOTUZUMAB | L01FX08 | IT | I | 27-01-2022 | EMEA/H/C/003967 | 11-05-2016 | VALID | |
| MOGAMULIZUMAB | L01FX09 | IT | I | 15-07-2020 | VALID | |||
| OLARATUMAB | L01FX10 | IT | Not authorised | 27-01-2022 | VALID | |||
| TAFASITAMAB | L01FX12 | IT | I | 19-10-2021 | EMEA/H/C/005436 | 26-08-2021 | VALID | |
| ENFORTUMAB VEDOTIN | L01FX13 | IT | I | 18-11-2022 | EMEA/H/C/005392 | 13-04-2022 | VALID | |
| POLATUZUMAB VEDOTIN | L01FX14 | IT | I | 27-01-2022 | VALID | |||
| SACITUZUMAB GOVITECAN | L01FX17 | IT | I | 28-04-2022 | EMEA/H/C/005182 | 22-11-2021 | VALID | |
| AMIVANTAMAB | L01FX18 | IT | I | 28-04-2022 | EMEA/H/C/005454 | 09-12-2021 | VALID | |
| TREMELIMUMAB | L01FX20 | IT | I | 18-08-2023 | EMEA/H/C/004650 | 20-02-2023 | VALID | |
| LONCASTUXIMAB TESIRINE | L01FX22 | IT | I | 18-08-2023 | EMEA/H/C/005685 | 20-12-2022 | VALID | |
| GLOFITAMAB | L01FX28 | IT | I | 14-11-2023 | EMEA/H/C/005751 | 07-07-2023 | VALID | |
| TALQUETAMAB | L01FX29 | IT | I | 14-11-2023 | EMEA/H/C/005864 | 21-08-2023 | VALID | |
| ZOLBETUXIMAB | L01FX31 | IT | POM | 01-08-2025 | EMEA/H/C/005868 | 19-09-2024 | VALID | |
| ELRANATAMAB | L01FX32 | IT | I | 13-05-2024 | EMEA/H/C/005908 | 07-12-2023 | VALID | |
| PERTUZUMAB AND TRASTUZUMAB | L01FY01 | IT | I | VALID | ||||
| NIVOLUMAB AND RELATLIMAB | L01FY02 | IT | I | 18-11-2022 | EMEA/H/C/005481 | 15-09-2022 | VALID | |
| OXALIPLATIN | L01XA03 | IT | I | None | VALID | |||
| PROCARBAZINE | L01XB01 | IT | I | None | VALID | |||
| TRASTUZUMAB | L01XC03 | IT | I | 13-05-2024 | EMEA/H/C/005769 | 15-11-2023 | VALID | |
| CETUXIMAB | L01XC06 | IT | I | None | VALID | |||
| METHYL AMINOLEVULINATE | L01XD03 | IT | I | None | VALID | |||
| AMINOLEVULINIC ACID | L01XD04 | IT | POM | 18-08-2017 | EMEA/H/C/000744 | 07-09-2007 | VALID | |
| PADELIPORFIN | L01XD07 | IT | I | 04-05-2018 | EMEA/H/C/004182 | 15-11-2017 | VALID | |
| FEDRATINIB | L01XE57 | IT | I | 01-06-2021 | EMEA/H/C/005026 | 08-02-2021 | VALID | |
| BEXAROTENE | L01XF03 | IT | I | 23-01-2019 | VALID | |||
| BORTEZOMIB | L01XG01 | IT | I | 09-03-2020 | VALID | |||
| CARFILZOMIB | L01XG02 | IT | I | VALID | ||||
| IXAZOMIB | L01XG03 | IT | POM | 18-08-2017 | EMEA/H/C/003844 | 21-11-2016 | VALID | |
| PANOBINOSTAT | L01XH03 | IT | I | 05-01-2021 | EMEA/H/C/003725 | 28-08-2015 | VALID | |
| VISMODEGIB | L01XJ01 | IT | I | VALID | ||||
| SONIDEGIB | L01XJ02 | IT | I | 06-01-2021 | EMEA/H/C/002839 | 14-08-2015 | VALID |